September 23, 2021
Video
An expert reviews the ongoing ARIEL4 phase III trial and explains what the future of ovarian cancer treatment looks like.
September 23, 2021
Video
Lyndsay Willmott, MD, explains the tolerability of PARP inhibitors for ovarian cancer and how to discuss dose reductions with patients.
September 23, 2021
Video
A key opinion leader shares data from a phase III, ARIEL3, clinical trial on rucaparib maintenance treatment for ovarian cancer.
September 23, 2021
Video
Dr. Lyndsay Willmott discusses the front-line therapy options for ovarian cancer and the factors considered in choosing maintenance therapies.
September 23, 2021
Video
An oncologist explains the importance of molecular testing in ovarian cancer and the implications of testing on treatment selection.
September 23, 2021
Video
Lyndsay Willmott, MD, presents the case of a 57-year-old woman with ovarian cancer.